Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1995
11/15/1995CN1111507A Controlled release oxybutynin formulations
11/15/1995CN1111506A Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
11/15/1995CN1111505A Medicine membrane for curing stomatocace
11/14/1995US5466849 Siloxane derivatives, producing method thereof and agents including siloxane derivative
11/14/1995US5466681 Receptor conjugates for targeting penicillin antibiotics to bacteria
11/14/1995US5466587 Method for introducing a biological substance into a target
11/14/1995US5466461 Polysaccharide esters
11/14/1995US5466451 Carbon dioxide, supercritical
11/14/1995US5466446 Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
11/14/1995CA2149282A1 Gemfibrozil containing pharmaceutical compositions
11/10/1995CA2147390A1 Process for the production of a concentrate of polyunsaturated fatty acid esters
11/09/1995WO1995030020A1 Novel nucleic acid/polymer complexes, method for preparing same and use thereof for cell transfection
11/09/1995WO1995029923A1 Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity
11/09/1995WO1995029916A1 Electron-deficient porphyrins and processes and intermediates for preparing same
11/09/1995WO1995029915A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds
11/09/1995WO1995029704A1 Cell lines obtained by in vivo migration and by fusion with autoimmune cells
11/09/1995WO1995029702A1 Texaphyrin solid-supports and devices
11/09/1995WO1995029701A1 Vaccines for oral immunization against infecting agents
11/09/1995WO1995029683A1 Pharmaceutical composition comprising hyaluronic acid for the clearing of arteriosclerosis
11/09/1995WO1995029678A1 Pharmaceutical composition for transdermal delivery
11/09/1995WO1995029677A1 Lactone stable formulation of camptothecin or 7-ethyl camptothecin
11/09/1995WO1995029673A1 Methods for modulating t cell responses by manipulating intracellular signal transduction
11/09/1995WO1995029665A1 Effective dosage form for antiepileptic drugs
11/09/1995WO1995029664A1 Modulated release from biocompatible polymers
11/09/1995CA2575042A1 Effective dosage form for antiepileptic drugs
11/09/1995CA2189469A1 Vaccines for oral immunization against infecting agents
11/09/1995CA2189435A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds
11/09/1995CA2187949A1 Electron-deficient porphyrins and processes and intermediates for preparing same
11/08/1995EP0680990A1 Collagen-synthetic polymer matrices prepared using a multiple step reaction
11/08/1995EP0680989A1 Crystal ferromagnetic compounds from naphtylamine and amino aromatic compounds copolymer derivatives
11/08/1995EP0680975A1 Acylated gamma-cyclodextrins
11/08/1995EP0680759A1 Transdermal delivery of calcium channel blockers, such as nifedipine
11/08/1995EP0680754A2 Percutaneous absorption preparation containing Buprenorphine
11/08/1995EP0680752A2 Conditioned water soluble substances
11/08/1995EP0680751A1 Lipid vesicles
11/08/1995EP0680748A1 Cosmetic and/or dermatological composition containing a cationic polymeric gelling agent and its uses especially for skin depigmentation
11/08/1995EP0680495A1 Structured copolymers used as absorbents, gels and carriers of metal ions
11/08/1995EP0680340A1 Amplified direction of effector groups to specific target cells in an animal
11/08/1995EP0680338A1 Ganglioside-klh conjugate vaccines with qs-21
11/08/1995EP0680335A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide
11/08/1995EP0680320A1 Stable oral ci-981 formulation and process of preparing same
11/08/1995EP0615439B1 Slow-release ibuprofen-containing medicament and its use
11/08/1995EP0572486B1 Delayed release oral dosage forms for treatment of intestinal disorders
11/08/1995EP0548096B1 Amphiphilic fluorine derivatives with telomeric structures; preparation and biomedical applications
11/08/1995EP0512109B1 Oral pharmaceutical composition containing cyclosporin and process for preparing same
11/08/1995EP0434765B1 Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages
11/08/1995CN1111445A Pharmaceutical emulsions containing bioactive steroids
11/08/1995CN1111130A Stable lyophilized thiotepa composition
11/08/1995CN1111128A Topical anti-inflammatory compositions containing piroxican
11/07/1995US5464932 Photocrosslinkable polyphosphazenes and their use as microencapsulation materials
11/07/1995US5464815 Extending plasma half-life of selectin by coadministering with compound which inhibits binding of selectin to low affinity heparin-like site on surface of cells of organ perfused with blood; assaying sensitivity; pharmaceutical composition
11/07/1995US5464634 Red blood cell surrogate
11/07/1995US5464629 Method of forming hydrogel particles having a controlled size using liposomes
11/07/1995US5464614 Stabilized superoxide dismutase (SOD) composition
11/07/1995US5464612 Solid preparation comprising ion exchanger and active agent
11/07/1995US5464013 Medical scanning and treatment system and method
11/07/1995CA2148764A1 Copolymer ferromagnetic crystalline compounds derived from naphthylamine and aminoaromatic compounds
11/07/1995CA2147918A1 Percutaneous absorption preparation
11/07/1995CA2060048C Skin cream preparation for external use
11/07/1995CA1337516C Polylactide compositions
11/03/1995CA2143923A1 Collagen-synthetic polymer matrices prepared using a multiple step reaction
11/02/1995WO1995029256A1 Chondroitinases i and ii, methods of preparation, and use thereof
11/02/1995WO1995029186A1 Compositions and methods for cell transformation
11/02/1995WO1995029178A1 Method for stabilizing compound dx-52-1 and lyophilized composition thereof
11/02/1995WO1995029172A1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes
11/02/1995WO1995028967A1 Contrast agents
11/02/1995WO1995028966A1 Dendrimeric compounds
11/02/1995WO1995028965A1 High solubility multicomponent inclusion complexes consisting of an acidic drug, a cyclodextrin and a base
11/02/1995WO1995028964A1 Collagen preparation for the controlled release of active substances
11/02/1995WO1995028963A1 Colon-specific drug release system
11/02/1995WO1995028954A1 Formulations for factor ix
11/02/1995WO1995028951A1 Formulations for il-11
11/02/1995WO1995028932A1 Transdermal delivery of alpha adrenoceptor blocking agents
11/02/1995WO1995028930A1 Dosage forms and method for ameliorating male erectile dysfunction
11/02/1995WO1995028927A1 Polymer coated tablet comprising amoxycillin and clavulanate
11/02/1995WO1995028923A1 Taxane class derivative based pharmaceutical compositions
11/02/1995WO1995028920A1 Acids and acid salts and their use in delivery systems
11/02/1995WO1995028918A1 A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating
11/02/1995WO1995028917A1 Once-a-day metoprolol oral dosage form
11/02/1995WO1995028916A1 Sustained release excipient
11/02/1995WO1995028915A1 Red blood cell surrogate
11/02/1995WO1995028914A1 Percutaneously administrable base composition and percutaneously administrable drug composition prepared therefrom
11/02/1995WO1995028849A1 Non-separable starch-oil compositions
11/02/1995WO1995028838A1 Modified amino acids for drug delivery
11/02/1995EP0679628A1 Polyene derivatives, pharmaceutical and cosmetic composition containing them and their use
11/02/1995EP0679401A1 Composition for curing lesioned tissue, process for producing the same, and use thereof
11/02/1995EP0679400A1 Oral dosage forms of azithromycin avoiding drugfood interaction
11/02/1995EP0679398A1 Immunopotentiating and infection protective agent and production thereof
11/02/1995EP0679395A1 Pharmaceutical compositions containing a ketoprofen solution in a soft gelatine capsule and method to produce them
11/02/1995EP0679391A2 Solid pharmaceutical dosage form containing flavored film coating
11/02/1995EP0679388A1 Cosmetic and/or dermatologic skin depigmentation composition and its use
11/02/1995EP0679339A1 Processing aid for making shearform matrix
11/02/1995EP0679163A1 Growth differentiation factor-3
11/02/1995EP0679095A1 Modified insulin-like growth factors
11/02/1995EP0679094A1 Compounds for targeting
11/02/1995EP0679083A1 Prevention and treatment of sepsis
11/02/1995EP0679079A1 Solution containing igf-1
11/02/1995CA2188682A1 Method for stabilizing compound dx-52-1 and lyophilized composition thereof
11/02/1995CA2188496A1 Polymer coated tablet comprising amoxycillin and clavulanate
11/02/1995CA2188467A1 Modified amino acids for drug delivery